Novartis (NVS)

Add to Watchlists
Create an Alert
98.35 -0.27  -0.27% NYSE Jul 7, 1:36PM Delayed 2m USD

Novartis Enterprise Value:

254.37B for July 6, 2015

View 4,000+ financial data types

View Full Chart

Novartis Enterprise Value Chart

Export Data
Save Image

Novartis Historical Enterprise Value Data

View and export this data going back to 1996. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
July 6, 2015 254.37B
July 2, 2015 257.20B
July 1, 2015 254.13B
June 30, 2015 253.70B
June 29, 2015 254.15B
June 26, 2015 257.49B
June 25, 2015 259.65B
June 24, 2015 261.59B
June 23, 2015 264.35B
June 22, 2015 262.77B
June 19, 2015 258.14B
June 18, 2015 261.42B
June 17, 2015 260.32B
June 16, 2015 260.58B
June 15, 2015 257.94B
June 12, 2015 262.05B
June 11, 2015 264.30B
June 10, 2015 263.99B
June 9, 2015 258.98B
June 8, 2015 261.13B
June 5, 2015 261.18B
June 4, 2015 265.00B
June 3, 2015 266.53B
June 2, 2015 264.73B
June 1, 2015 265.55B
   
May 29, 2015 264.23B
May 28, 2015 267.87B
May 27, 2015 266.15B
May 26, 2015 262.02B
May 22, 2015 266.92B
May 21, 2015 269.17B
May 20, 2015 266.08B
May 19, 2015 266.80B
May 18, 2015 267.42B
May 15, 2015 266.68B
May 14, 2015 267.04B
May 13, 2015 264.08B
May 12, 2015 263.44B
May 11, 2015 263.49B
May 8, 2015 264.68B
May 7, 2015 261.45B
May 6, 2015 261.59B
May 5, 2015 262.89B
May 4, 2015 266.34B
May 1, 2015 265.72B
April 30, 2015 262.00B
April 29, 2015 264.25B
April 28, 2015 267.16B
April 27, 2015 267.06B
April 24, 2015 267.95B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Advertisement

NVS Enterprise Value Benchmarks

Companies
AstraZeneca 89.22B
Bristol-Myers Squibb 112.51B
GlaxoSmithKline 119.23B

NVS Enterprise Value Range, Past 5 Years

Minimum 106.70B Jul 21 2010
Maximum 270.87B Apr 23 2015
Average 186.30B

NVS Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("NVS", "enterprise_value")
  • Last 5 data points: =YCS("NVS", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.